Amy Proal, PhD

It was great to do this podcast. Persistent #viruses - and many bacteria, fungi and even parasite pathogens - directly hijack our #mitochondria. They can hack and distort human gene signaling that controls senescence & inflammaging. This knowledge is huge for longevity treatments

It was great to be on the Tick Boot Camp podcast. I talk about Chronic Lyme & Long COVID diagnostics and disease mechanisms, with a focus on the fact that “the issue is in tissue!” Listen here: tickbootcamp.com/episode-558-pe… @TickBootCamp

@khoney @BayAreaLyme @HHSGov So great to be on the panel with you Kristen! The tipping point is definitely here!

💚💚💚 Lyme Tipping Point is here One for All, and All for One. #LongCOVID #ME #MCS @HHSGov is making invisible illness 🫥 visible w data, tech, patient-centered innovation & partnerships Where there is controversy, we need more data #OpenData Together, let’s change the status quo—join us! lymexvisiblevoicesprize.com

@Dr_Haridopolos @Surgeon_General It was amazing to be on the panel! The energy at the meeting was incredible, and I’m more motivated than ever to help build a next-generation of diagnostics for women (and everyone!) who suffer from chronic Lyme

Honored to moderate the Lyme and Autoimmune disease panel at the HHS inaugural National Conference on Women’s Health in DC today. ⁦⁦@Surgeon_General⁩

So glad to join today’s HHS #Lyme & Invisible Illness panel! Via @polybioRF we are validating novel diagnostic tests to identify chronic infections missed by current bloodwork. These diagnostics will help make the invisible visible in Chronic Lyme, Long COVID & related conditions

@SawyerBlatz @polybioRF Thanks Sawyer we are so grateful for your support!

Incredibly grateful for all the hard work @polybioRF is doing to find treatments for #LongCovid ❤️

PolyBio’s core team is proud to be working with Invivyd on a clinical trial of the monoclonal VYD2311 for Long Covid and Covid vaccine-injured patients. Dr. Amy Proal, PolyBio CEO and SPEAR founding member stated:“chronic exposure to SARS-CoV-2 spike protein in any form may be driving ongoing morbidity in America, and we believe the mAbs developed by Invivyd may provide an extremely promising route to stopping, and perhaps reversing, some of that damage.”

13/ Overall, converging evidence places persistent infection at the heart of the #Alzheimer’s disease process, opening up the door to many more #infection-combating therapies in the space

12/ Worth noting then that lithium has long been understood to have antiviral properties. For example this study found that lithium chloride inhibits herpes simplex virus replication in cell cultures: pubmed.ncbi.nlm.nih.gov/6256617/

1/ This important new study found that herpes simplex #virus 1 infection can drive the formation of tau tangle aggregates - protein clumps that facilitate the death of neurons in the #Alzheimer’s brain: nature.com/articles/s4159…

It was hugely motivating to be at the HHS #Lyme Disease Roundtable (pictured here w/ Ben Nemser from the Steven & Alexandra Cohen Foundation). I am excited to continue moving forward new diagnostics & trials for patients with chronic tick-borne/vector-borne illness